FarrowJE, BlomTJ, KwokWY, et al.Prevalence and correlates of eating disorder symptoms in adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol, 2024; doi: 10.1089/cap.2024.0003
2.
FindlingRL, ZhouX, GeorgeP, et al.Diagnostic trends and prescription patterns in disruptive mood dysregulation disorder and bipolar disorder. J Am Acad Child Adolesc Psychiatry, 2022; 61(3):434–445; doi: 10.1016/j.jaac.2021.05.016
3.
LyuN, RowanPJ, AbughoshS, et al.Trajectories and predictors for the development of clinically significant weight gain in children and adolescents prescribed second-generation antipsychotics. J Child Adolesc Psychopharmacol, 2024; doi: 10.1089/cap.2023.0071
4.
PanPY, YehCB. Characteristic similarities of irritability between autism and disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol, 2023; 33(10):428–432; doi: 10.1089/cap.2023.0035
5.
RadeckiDT, RobiesonWZ, GopalkrishnanM, et al.Safety and efficacy of levomilnacipran extended release in pediatric patients aged 7-17 years with major depressive disorder: Results of two phase 3, randomized, Double-Blind Studies. J Child Adolesc Psychopharmacol, 2024; doi: 10.1089/cap.2023.0080
6.
SaitoT, TakahashiH, TsujiiN, et al.Efficacy of preventing relapse evaluated by a multicenter randomized Double-Blind Placebo-Controlled Withdrawal Study of escitalopram in Japanese adolescents with major depressive disorder. J Child Adolesc Psychopharmacol, 2023; 33(10):418–427; doi: 10.1089/cap.2023.0048Dec
7.
SchwartzJJ, RoskeC, LiuQ, et al.C-Reactive protein does not predict future depression onset in adolescents: Preliminary findings from a Longitudinal Study. J Child Adolesc Psychopharmacol, 2024; doi: 10.1089/cap.2023.0091
8.
SøndergaardNR, NørøxeKB, CarlsenAH, et al.Switch to lisdexamfetamine in the treatment of attention-deficit disorder at a psychiatric outpatient clinic for school-aged children: A Danish Cohort Study. J Child Adolesc Psychopharmacol, 2024; 34(3):137–147; doi: 10.1089/cap.2023.0077
9.
WigginsJL, Briggs-GowanMJ, BrotmanMA, et al.Toward a developmental nosology for disruptive mood dysregulation disorder in early childhood. J Am Acad Child Adolesc Psychiatry, 2021; 60(3):388–397; doi: 10.1016/j.jaac.2020.04.015
10.
ZhangY, ZhangW, YuE. Systematic review and meta-analysis: Pharmacological and nonpharmacological interventions for disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol, 2024; doi: 10.1089/cap.2024.0013
